OverviewManufacturing & Research FacilityManagementBoard of DirectorsCareers

Board of Directors

William M. Mitchell, M.D., Ph.D.
Chairman of the Board

WILLIAM M. MITCHELL, M.D., Ph.D., was appointed Chairman of the Board in February 2016 after serving as a Director since July 1998.  Dr. Mitchell is a Professor of Pathology, Microbiology & Immunology at Vanderbilt University School of Medicine and is a board certified physician. Dr. Mitchell earned a M.D. from Vanderbilt and a Ph.D. from Johns Hopkins University, where he served as House Officer in Internal Medicine (Osler Service), followed by a Fellowship at its School of Medicine. Dr. Mitchell has published over 200 papers, reviews and abstracts that relate to the pathogenesis of obligate intracellular pathogens, innate and adaptive immune responses, and liquid biopsy cancer (chromosomal instability) diagnostics. He is the inventor or co-inventor of 14 issued US patents as well as derivative foreign patents. Dr. Mitchell has worked with many professional societies that have included the American Society of Investigative Pathology (ASIP), the International Society for Antiviral Research (ISAR), the American Society of Biochemistry and Molecular Biology (ASBMB), the American Society of Microbiology (ASM), and the American Society of Clinical Oncology (ASCO). Dr. Mitchell is a member of the American Medical Association (AMA). He has served on numerous review committees for the National Institutes of Health (NIH), the Centers for Disease Control (CDC), the European Union (EU), and the College of American Pathology (CAP). He is an independent director of Chronix Biomedical, a genetics based cancer diagnostic company.

Thomas K. Equels, M.S., J.D.
Executive Vice Chairman, Chief Executive Officer, President

THOMAS K. EQUELS, M.S. J.D., was named Chief Executive Officer in February 2016, served as President since August 2015, has been a Director since 2008 and presently serves as our Executive Vice Chairman. Mr. Equels previously served as Secretary from 2008 to 2016, General Counsel from 2010 to 2016, and Chief Financial Officer from December 2013 to February 2016. While serving full-time at Hemispherx, Mr. Equels has been the President and Managing Director of the Equels Law Firm based in Miami Florida that focuses on litigation. For over a quarter century, Mr. Equels has represented national and state governments as well as companies in the banking, insurance, aviation, pharmaceutical and construction industries. On numerous occasions, Mr. Equels has been the court appointed receiver to turnaround distressed companies. Mr. Equels received his Juris Doctor degree with high honors from Florida State University. He is a summa cum laude graduate of Troy University and also obtained his Masters' Degree in Management from Troy. He is a member of the Florida Bar Association and the American Bar Association.

Stewart L. Appelrouth

STEWART L. APPELROUTH has served as a member of the Board of Directors since August 2016.  Mr. Appelrouth is a certified public accountant and partner at Appelrouth Farah & Co., P.A., Certified Public Accountants and Advisors. Mr. Appelrouth is also a certified forensic accountant and possesses 40 years of experience in Accounting and Consulting. He is a member of or has affiliations with the AICPA, American College of Forensic Examiners, Association of Certified Fraud Examiners, Florida Bar Grievance Committee, Florida Institute of Certified Public Accountants and InfraGard Member, a national information sharing program between the Federal Bureau of Investigation and the private sector. Mr. Appelrouth graduated from Florida State University in 1975 and his Master’s Degree in Finance from Florida International University in 1980.


Site Map | Privacy | Terms Of Use Copyright   Hemispherx Biopharma, Inc. | All Rights Reserved.